Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile.
Clostridioides difficile infection (CDI) is the primary cause of hospital-acquired diarrhea, and responsible for over 500,000 enteric infections a year in the United States alone. Although most patients with CDI are successfully treated with metronidazole or vancomycin, the high rate of recurrence i...
Guardado en:
Autores principales: | Alexis Fong, Megan Ross, Justin Boudreau, Reza Nokhbeh, Kim Tilbe, Hoyun Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81d1e77f48bb42818e9e32cdc31980c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epidemiology of Clostridioides difficile in South Africa.
por: Pieter de Jager, et al.
Publicado: (2021) -
Faecal transplantation and Clostridioides difficile infection
por: Knežević Darija A., et al.
Publicado: (2021) -
Bile acid-independent protection against Clostridioides difficile infection.
por: Andrea Martinez Aguirre, et al.
Publicado: (2021) -
Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
por: Megan G Taggart, et al.
Publicado: (2021) -
Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Ilse M. Boekhoud, et al.
Publicado: (2020)